Beckett, A.H., & Rowland, M. (1965). Urinary excretion kinetics of methylamphetamine in man. Nature. 206:1260-1261.
Belpaire, F.M., Wijnant. P., Temmermann, A., et al. (1998). The oxidative metabolism of metoprolol in human liver microsomes: inhibition by the selective serotonin reuptake inhibitor. Eur J Clin Pharm. 54(3): 261-264.
Coleman, M.D. (2010). Human drug metabolism, an introduction. Wiley-Blackwell.
Griffin, C.E., Kaye, A.M., & Bueno, F.R. (2013). Benzodiazepine pharmacology and central nervous system-mediated effects. Ochsner J.13(2): 214-223.
Gunaraha, C. (2000). Drug metabolism & pharmacokinetics in drug discovery: a primer for bioanalytical chemists, part 1. Curr Sep. 19(1): 19-21.
Hesse, L.M., He, P., & Krishnaswamy, S., et al. (2004). Pharmacogenetic determinants of interindividual variability in bupropion hydroxylation by cytochrome P450 2B6 in human liver microsomes. Pharmacogenetics. 14(4): 225–238.
Kaplan, L.A., Pesce, A.J. (1996). Clinical chemistry theory, analysis, correlation. Mosby.
Klaassen, C.D., & Watkins, III, J.B. (2015). Casarett & Doull’s essentials of toxicology. (3rd ed.). McGraw-Hill.
Milsap, R.L., & Jusko, W.L. (1994). Pharmacokinetics in the infant. Environ Health Perspect. 102(11): 107-109.
Smith, H. (2009). Opioid metabolism. Mayo Clin Proc. 84(7): 615–616.
Yamada, H., Ishii, Y., & Oguri, K. (2005). Metabolism of drugs of abuse: its contribution to the toxicity and the inter-individual differences in drug sensitivity. J of Health Science. 51(1): 1-4.